NENicole Arias Espinoza

Nicole Arias Espinoza

*This is an algorithmically generated author record based on publicly available information.

Nicole Arias Espinoza has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparative Analysis of RNA-seq Pipelines Across Computing Environments for Generating Machine-Learning Outcomes

    by Nicole Arias Espinoza, Alonso Segura Valverde, Susana Mesen-Porras

    Transcriptomics enables comprehensive analysis of RNA molecules, with RNA-sequencing providing key insights into gene expression. However, bioinformatics analyses remain limited by the chosen strategy, an aspect that can be improved through machine learning integration. This study compared three RNA-seq pipelines (step-by-step, nf-core, and OneStop) implemented in HPC and GUI environments, using data from BioProject GSE130437 of breast cancer MCF7 cell lines resistant and susceptible to palbociclib. All pipelines identified a comparable number of genes ($\sim 14000$ per condition), but each detected unique subsets not shared across methods. Differential gene expression analysis revealed distinct transcriptomic profiles, with limited overlap among pipelines. LUM, KCNK2, and LINC00052 transcripts were consistently identified across pipelines and in the reference study, while others appeared only in a pipeline-specific context, highlighting biases introduced by preprocessing steps, statistical models, and default parameters. Performance assessments demonstrated trade-offs, the step-by-step approach offered flexibility but required high expertise and longer runtimes; nfcore achieved the fastest and most reproducible results through containerized workflows; and OneStop provided the most user-friendly interface, although scalability and parameter customization were limited. Overall, pipeline selection substantially impacts DEG outcomes and downstream interpretations. Considering scalability, reproducibility, and machine learning integration, nf-core proved the most practical choice for large datasets, while OneStop lowered entry barriers for non-specialists. These findings emphasize the need for careful pipeline selection and the development of ML-ready outputs to strengthen reproducibility and expand transcriptomics applications toward predictive modeling and personalized medicine.

  • Open Access

    Evaluation of the antimicrobial properties of natural extracts of Ganoderma lucidum

    by Karina Abarca-Cascante, Nicole Arias-Espinoza, Judith Cambronero-Vega, Bryan Zúñiga-Gaitán, Victor Álvarez-Valverde, José B Azofeifa-Bolaños, Jorengeth Rodríguez-Rodríguez

    There is a growing importance of alternative anticancer and anti-inflammatory treatments. Current interest lies in natural medicine and secondary metabolites present in plants, particularly focusing on triterpenes. Ganoderma lucidum is a fungal species of significant commercial interest due to its therapeutic and medicinal properties resulting from secondary metabolites such as polysaccharides and triterpenes. These compounds exhibit antitumor activity and bolster the immune system. The study aimed to assess the antimicrobial activity of G. lucidumextracts, both commercial and wild. The content of ganoderic acids in all extracts showed a slight difference in concentration between commercial and wild extracts. However, no bacterial inhibition halos were observed in any of the strains used. The presence of varying concentrations of ganoderic acids among treatments underscores the importance of optimizing and standardizing a comprehensive strategy for extracting secondary metabolites, focusing on producing high-quality supplements and pharmaceutical products. Furthermore, preserving the stability of the obtained triterpenes is necessary due to their importance in the medicinal properties of the fungus.